29
Jul 2026
Researchers find potential pathway to improve glioblastoma treatment
New research published in Neuro-Oncology gives a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes.
29
Jul 2026
New research published in Neuro-Oncology gives a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes.
29
Jul 2026
Los Angeles County residents living in evacuation warning or order zones during the 2025 wildfires experienced heightened levels of anxiety and depression almost a year later, according to new USC research.
29
Jul 2026
The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies.
29
Jul 2026
Malaria is the deadliest climate-sensitive infectious disease. Yet, researchers and public health officials have long argued over how climate change has shaped its spread.
29
Jul 2026
Traumatic injuries, whether on a battlefield or in a car accident, often involve damaged blood vessels that require immediate repair.
29
Jul 2026
A new home test can detect type 2 diabetes or prediabetes with high accuracy. The test has been developed using artificial intelligence and large amounts of health data – and surprisingly, one of the steps involves measuring the length of your thigh.
29
Jul 2026
A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart muscle disease, a phase 3 clinical trial published in The Lancet has found.
29
Jul 2026
Real-time off-gas analysis helps optimize fermentation by improving process control, reducing failed batches and supporting faster development.
29
Jul 2026
The American College of Lifestyle Medicine (ACLM) today announced the launch of Project Remission, a call to action to shift the goal of chronic disease care from symptom management to the possibility of achieving remission and health restoration.
29
Jul 2026
Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class pan-TEAD inhibitor driven by Insilico's proprietary AI, has received Fast Track Designation (FTD) from the U.S.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more